H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
18%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Balneological treatment as prematurity prevention

Agata Karowicz-Bilińska, Małgorzata Bieńkiewicz, Ewa Kuś, Wojciech Kazimierak, Teresa Pajszczyk-Kieszkiewicz

Med Sci Monit 1996; 2(2): CR209-211

ID: 499575

Published: 1996-03-01


Sterility and infertility are the most common indications for balneological treatment. In such patients uterine hypoplasia is often responsible for pregnancy loss. Balneology causes the uterine mass enlargment and stimulates the ovarian function. Three groups of women with hypoplastic uteruses were included in the study. Group I - consisted of women treated balneologically for hypoplasia of the uterus. Group II - consisted of women treated balneologically for ovarian dysfunction and uterine hypoplasia. Group III - served as the control group and included women treated hormonally for uterine hypoplasia. All women were monitored in the Institute of Gyneacology and Obstetrics before pregnancy and also delivered there. Most of the examined women were between 25-29. More than 60% of the women were infertile or sterile for at least 3 yrs. For 60% of women from group I and II the balneological treatment was the first method applied. The most frequent pathological symptom observed during pregnancy was premature uterine contractility. In the group of women treated hormonally (group III) indications for beta-adrenomimetic treatment were more frequent as compared to the other groups. In the same group the prematurity rate was significantly higher as compared to the other groups. The caesarean section rate was similar in all the examined groups.

Keywords: balneotherapy, uterine hypoplasia, ovarian dysfunction, prematurity



Back